Keywords: dov, initiates, phase, trial, depression, drug, new

DOV initiates Phase I trial of depression drug

Article | 07 March 2005

Print This

New Jersey, USA-based DOV Pharmaceutical has initiated the first Phase I clinical trial with DOV 102,677, a potential potent inhibitor of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in